BAYESIAN NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)

被引：2
|
作者：
Pacou, M. [1 ]
Taieb, V [1 ]
Abrams, K. R. [2 ]
Diels, J. [3 ]
van Sanden, S. [4 ]
Garg, M. [5 ]
Schroeder, M. [6 ]
Kaur, V
Nielsen, A. T. N. [5 ]
Nuhoho, S. [6 ]
Neslusan, C. [7 ]
Hemels, M. [5 ]
机构：
[1] Amaris, London, England
[2] Inst Canc Res, Sutton, Surrey, England
[3] Janssen Pharmaceut, B-2340 Beerse, Belgium
[4] Janssen EMEA, EMEA HEMAR Analyt, Beerse, Belgium
[5] Janssen Cilag, Birkerod, Denmark
[6] Janssen UK, High Wycombe, Bucks, England
[7] Janssen Global Serv LLC, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.623
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [1] BAYESIAN NETWORK META-ANALYSIS TO ASSESS RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH METFORMIN
    Pacou, M.
    Taieb, V
    Abrams, K. R.
    Diels, J.
    van Sanden, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Nielsen, A. T. N.
    Nuhoho, S.
    Neslusan, C.
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A609 - A609
  • [2] NETWORK META-ANALYSIS (NMA) TO ASSESS RELATIVE EFFICACY MEASURED AS PERCENTAGE OF PATIENTS TREATED TO HBA1C TARGET WITH CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)
    Taieb, V
    Pacou, M.
    Schroeder, M.
    Schubert, A.
    Nielsen, A. T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
  • [3] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [4] BAYESIAN NETWORK META-ANALYSIS (NMA) TO ASSESS THE RELATIVE EFFICACY OF CANAGLIFLOZIN MONOTHERAPY OVER 26 WEEKS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Schroeder, M.
    Taieb, V
    Belhadi, D.
    Seyla-Hammer, C.
    Hemels, M.
    Nielsen, A. T.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A56 - A56
  • [5] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus inadequately controlled with metformin plus sulphonylurea over 52 weeks
    Vercruysse, F.
    Charpentier, G.
    Wilding, J.
    Hollander, P.
    Gonzalez Galvez, G.
    Mathieu, C.
    Usiskin, K.
    Vijapurkar, U.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S373 - S373
  • [6] A NETWORK META-ANALYSIS (NMA) TO ASSESS THE LONGER-TERM RELATIVE EFFICACY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON METFORMIN
    Taieb, V
    Pacou, M.
    Schroeder, M.
    Nielsen, A. T.
    Schubert, A.
    Neslusan, C.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
  • [7] A BAYESIAN NETWORK META-ANALYSIS (NMA) FOR EVALUATING THE RELATIVE EFFICACY OF DUAL THERAPY COMBINATIONS OF DAPAGLIFLOZIN AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Bao, H.
    Peng, X.
    Li, W.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S43 - S43
  • [8] Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
    Rodbard, H. W.
    Seufert, J.
    Aggarwal, N.
    Cao, A.
    Fung, A.
    Pfeifer, M.
    Alba, M.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 812 - 819
  • [9] Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Sulfonylurea (SU) Monotherapy: A CANVAS Substudy
    Fulcher, Greg
    Matthews, David
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    Weiss, Robert
    Rosenstock, Julio
    Capuano, George
    Desai, Mehul
    Shaw, Wayne
    Vercruysse, Frank
    Meininger, Gary
    Neal, Bruce
    [J]. DIABETES, 2013, 62 : A292 - A292
  • [10] Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
    Lukashevich, V.
    Prato, S. D.
    Araga, M.
    Kothny, W.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 403 - 409
12345